High Healthcare Utilization in a Severe Asthma Population Despite Use of High Dose ICS/LABA

被引：0
|
作者：
Castro, M. [1 ]
Reaven, N.
Funk, S.
Jarjour, N. [2 ]
机构：
[1] Washington Univ, St Louis, MO 63130 USA
[2] Univ Wisconsin, Madison, WI 53706 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1275
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA plus LAMA in asthma patients - TAILOR study
    Verhamme, K. M.
    De Ridder, M.
    Rijnbeek, P.
    Mosseveld, M.
    Pedersen, L.
    Marconi, E.
    Lapi, F.
    Tan, C.
    Delmestri, A.
    Prieto-Alhambra, D.
    Nudo, E.
    Brusselle, G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study
    Canonica, G. W.
    Virchow, J.
    Kots, M.
    Zuccaro, F.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma
    Beasley, Richard
    Fingleton, James
    Weatherall, Mark
    [J]. THORAX, 2013, 68 (02) : 119 - 120
  • [4] Six Months Step Down Treatment From High Dose ICS/LABA Combination Therapy In Asthma
    Paggiaro, P.
    Nicolini, G.
    Crimi, N.
    Fabbri, L.
    Olivieri, D.
    Rossi, A.
    Papi, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [5] THE DOSE OF ICS IN TRIPLE ICS/LABA/LAMA FDC MODULATES INFLAMMATION IN A HUMAN EX VIVO MODEL OF SEVERE EOSINOPHILIC ASTHMA
    Rogliani, Paola
    Ora, Josuel
    Motta, Enrico
    Laitano, Rossella
    Calzetta, Luigino
    [J]. CHEST, 2023, 164 (04) : 4918A - 4918A
  • [6] A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment
    Kerwin, Edward
    Dorinsky, Paul
    Patel, Mehul
    Rossman, Kimberly
    Reisner, Colin
    Maes, Andrea
    Darken, Patrick
    Griffis, Dianne
    Fjallbrant, Harald
    [J]. JOURNAL OF ASTHMA, 2022, 59 (07) : 1420 - 1432
  • [7] THE COST-EFFECTIVENESS OF STEP DOWN FROM HIGH DOSE ICS/LABA COMBINATION THERAPY IN ASTHMA IN THE UK SETTING
    Paggiaro, P.
    Buseghin, G.
    Nicolini, G.
    Patel, S.
    Iannazzo, S.
    Zaniolo, O.
    Papi, A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A493 - A494
  • [8] THE ECONOMIC BURDEN OF ADULT ASTHMA THAT IS UNCONTROLLED ON MEDIUM-TO-HIGH-DOSE ICS-LABA: A SYSTEMATIC LITERATURE REVIEW
    Czira, A.
    Martin, A.
    Turner, M.
    Meeraus, W.
    Birch, H.
    Zhang, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S729 - S729
  • [9] Cost and Healthcare Utilization in Asthma Patients with High Oral Corticosteroid Use
    Raimundo, Karina
    Ngai, Ka M.
    Chang, Eunice
    Broder, Michael
    Griffin, Noelle M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB5 - AB5
  • [10] Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study
    Ohbayashi, Hiroyuki
    Hozawa, Soichiro
    Bertran, Alexandra
    Yoshisue, Hajime
    Tanaka, Hiroshi
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (07) : 656 - 667
12345